Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy.

Masuda T, Muto S, Fujisawa G, Iwazu Y, Kimura M, Kobayashi T, Nonaka-Sarukawa M, Sasaki N, Watanabe Y, Shinohara M, Murakami T, Shimada K, Kobayashi E, Kusano E.

Am J Physiol Heart Circ Physiol. 2012 May 1;302(9):H1871-83. doi: 10.1152/ajpheart.00663.2011. Epub 2012 Mar 2.

2.

Role of ANG II in coronary capillary angiogenesis at the insulin-resistant stage of a NIDDM rat model.

Jesmin S, Hattori Y, Sakuma I, Mowa CN, Kitabatake A.

Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1387-97.

3.
4.

Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis.

Jin D, Takai S, Sugiyama T, Hayashi T, Fukumoto M, Oku H, Kitaura Y, Ikeda T, Miyazaki M.

J Pharmacol Sci. 2009 Feb;109(2):275-84. Epub 2009 Feb 7.

5.

Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.

Fujiyama S, Matsubara H, Nozawa Y, Maruyama K, Mori Y, Tsutsumi Y, Masaki H, Uchiyama Y, Koyama Y, Nose A, Iba O, Tateishi E, Ogata N, Jyo N, Higashiyama S, Iwasaka T.

Circ Res. 2001 Jan 19;88(1):22-9. Retraction in: Circ Res. 2013 Jun 7;112(12):e180.

6.

Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy.

Rothermund L, Kreutz R, Kossmehl P, Fredersdorf S, Shakibaei M, Schulze-Tanzil G, Paul M, Grimm D.

Am J Hypertens. 2002 Jul;15(7 Pt 1):644-52.

PMID:
12118914
7.

Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.

Lu J, Yao YY, Dai QM, Ma GS, Zhang SF, Cao L, Ren LQ, Liu NF.

Cardiovasc Diabetol. 2012 Sep 7;11:105. doi: 10.1186/1475-2840-11-105.

8.

Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload.

Yamakawa H, Imamura T, Matsuo T, Onitsuka H, Tsumori Y, Kato J, Kitamura K, Koiwaya Y, Eto T.

Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2939-46.

9.

Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.

de Boer RA, Pokharel S, Flesch M, van Kampen DA, Suurmeijer AJ, Boomsma F, van Gilst WH, van Veldhuisen DJ, Pinto YM.

J Mol Med (Berl). 2004 Oct;82(10):678-87. Epub 2004 Aug 20.

PMID:
15322702
10.

Adaptive response of the heart to long-term anemia induced by iron deficiency.

Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T.

Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H585-93. doi: 10.1152/ajpheart.00463.2008. Epub 2009 Jan 9.

11.

Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.

Zhao Q, Ishibashi M, Hiasa K, Tan C, Takeshita A, Egashira K.

Hypertension. 2004 Sep;44(3):264-70. Epub 2004 Jul 19.

12.

Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.

Cao N, Wong YG, Rosli S, Kiriazis H, Huynh K, Qin C, Du XJ, Kemp-Harper BK, Ritchie RH.

Circ Heart Fail. 2015 May;8(3):572-81. doi: 10.1161/CIRCHEARTFAILURE.114.001699. Epub 2015 Mar 3.

13.

Involvement of angiotensin II-dependent vascular endothelial growth factor gene expression via NADPH oxidase in the retina in a type 2 diabetic rat model.

Fukumoto M, Takai S, Ishizaki E, Sugiyama T, Oku H, Jin D, Sakaguchi M, Sakonjo H, Ikeda T, Miyazaki M.

Curr Eye Res. 2008 Oct;33(10):885-91. doi: 10.1080/02713680802389851.

PMID:
18853323
14.

Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.

Kawano H, Cody RJ, Graf K, Goetze S, Kawano Y, Schnee J, Law RE, Hsueh WA.

Hypertension. 2000 Jan;35(1 Pt 2):273-9.

15.

Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes.

Sugiyama T, Okuno T, Fukuhara M, Oku H, Ikeda T, Obayashi H, Ohta M, Fukui M, Hasegawa G, Nakamura N.

Exp Eye Res. 2007 Sep;85(3):406-12. Epub 2007 Jun 19.

PMID:
17678894
16.

Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.

Hao PP, Yang JM, Zhang MX, Zhang K, Chen YG, Zhang C, Zhang Y.

Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1007-19. doi: 10.1152/ajpheart.00563.2014. Epub 2015 Feb 27.

17.

Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat.

DeMarco VG, Johnson MS, Habibi J, Pulakat L, Gul R, Hayden MR, Tilmon RD, Dellsperger KC, Winer N, Whaley-Connell AT, Sowers JR.

Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H181-90. doi: 10.1152/ajpheart.00883.2010. Epub 2010 Nov 5.

18.

Local angiotensin II aggravates cardiac remodeling in hypertension.

Xu J, Carretero OA, Liao TD, Peng H, Shesely EG, Xu J, Liu TS, Yang JJ, Reudelhuber TL, Yang XP.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1328-38. doi: 10.1152/ajpheart.00538.2010. Epub 2010 Sep 10.

19.

Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats.

Daniels A, Linz D, van Bilsen M, Rütten H, Sadowski T, Ruf S, Juretschke HP, Neumann-Haefelin C, Munts C, van der Vusse GJ, van Nieuwenhoven FA.

Eur J Heart Fail. 2012 Feb;14(2):193-201. doi: 10.1093/eurjhf/hfr166.

20.

Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.

Ikeda Y, Nakamura T, Takano H, Kimura H, Obata JE, Takeda S, Hata A, Shido K, Mochizuki S, Yoshida Y.

J Lab Clin Med. 2000 Apr;135(4):353-9.

PMID:
10779052
Items per page

Supplemental Content

Write to the Help Desk